![]() ![]() A study published June 26 in the Journal of the American Medical Association (JAMA) found that among patients with ischemic stroke, the use of intravenous tissue plasminogen activator (tPA) among warfarin-treated patients if their international normalized ration (INR) was 1.7 or lower, was not associated with increased symptomatic intracranial hemorrhage (sICH) risk compared with non-warfarin-treated patients.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |